Multi-gene panels that usually contain known high-risk cancer predisposing genes, such as BRCA1 and BRCA2, were used to determine the prevalence and spectrum of variants in the genes in defined study groups for comparative purposes. The gene discussed is BRCA2; the disease is cancer.